NCT07704450

Brief Summary

This interventional device feasibility study evaluates the operational feasibility of a prototype urinary electrolyte monitoring device in healthy adults aged 18 to 60 years. Urine samples will be collected during protocol-defined dietary intervention conditions and free-living conditions to determine whether the prototype device can generate complete urinary sodium, chloride, potassium, magnesium, and calcium measurement results without device malfunction, sample-processing failure, unreadable signal output, or repeat device operation. Dietary intervention conditions are used to provide physiologic variation in urinary electrolyte levels and to create testing conditions for the prototype device. The primary outcome is the valid measurement rate of the prototype device across collected urine samples. Secondary outcomes will summarize changes in urinary electrolyte levels following dietary interventions and within-participant variability under free-living conditions. Participants will provide baseline anthropometric and physiological data, including height, weight, age, and blood pressure, along with baseline fasting morning urine samples. Participants will consume assigned standardized meals or provide urine samples under free-living conditions, depending on study arm assignment. Longitudinal urine samples will be collected at protocol-defined time points, such as post-prandial intervals or other scheduled collection times during the study period.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
2mo left

Started Jul 2026

Shorter than P25 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Jul 2026Sep 2026

First Submitted

Initial submission to the registry

June 25, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 15, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

July 20, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

July 15, 2026

Status Verified

July 1, 2026

Enrollment Period

1 month

First QC Date

June 25, 2026

Last Update Submit

July 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prototype Device Valid Measurement Rate for Urinary Electrolyte Analysis

    Percentage of all collected urine samples for which the prototype device produces a complete urinary sodium, chloride, potassium, magnesium, and calcium measurement result without device malfunction, sample-processing failure, unreadable signal output, or need for repeat device operation. A valid measurement rate of 80% or higher will be considered to meet the protocol-defined feasibility criterion.

    Up to 2 weeks after study arm assignment.

Secondary Outcomes (5)

  • Change from baseline in urinary sodium, chloride, potassium, magnesium, and calcium levels following the high-fruit dietary intervention

    Baseline, 1 hour, 2 hours, 3 hours, and 4 hours after the high-fruit dietary intervention.

  • Change from baseline in urinary sodium, chloride, potassium, magnesium, and calcium levels following the high-nut dietary intervention

    Baseline, 1 hour, 2 hours, 3 hours, and 4 hours after the high-nut dietary intervention.

  • Change from baseline in urinary sodium, chloride, potassium, magnesium, and calcium levels following the calcium supplementation dietary intervention

    Baseline, 1 hour, 2 hours, 3 hours, and 4 hours after the calcium supplementation dietary intervention.

  • Change from baseline in urinary sodium, chloride, potassium, magnesium, and calcium levels following the DASH dietary intervention

    Baseline and daily for up to 2 weeks during the DASH dietary intervention.

  • Within-participant variability in urinary sodium, chloride, potassium, magnesium, and calcium levels under free-living conditions

    Daily for up to 1 week under free-living conditions.

Study Arms (5)

fruit diet (for potassium intake)

EXPERIMENTAL
Device: Urinary electrolyteDietary Supplement: fruit diet

nut diet (for magnesium intake)

EXPERIMENTAL
Device: Urinary electrolyteDietary Supplement: nut diet

Calcium supplement diet (for calcium intake)

EXPERIMENTAL
Device: Urinary electrolyteDietary Supplement: calcium supplement diet

DASH Diet (for low-salt and high-fruit intake)

EXPERIMENTAL
Device: Urinary electrolyteDietary Supplement: DASH diet

Uncontrol

EXPERIMENTAL
Device: Urinary electrolyte

Interventions

Urine is collected and tested on the device.

Calcium supplement diet (for calcium intake)DASH Diet (for low-salt and high-fruit intake)Uncontrolfruit diet (for potassium intake)nut diet (for magnesium intake)
fruit dietDIETARY_SUPPLEMENT

Participants will consume assigned standardized meals including fruit.

fruit diet (for potassium intake)
nut dietDIETARY_SUPPLEMENT

Participants will consume assigned standardized meals including nut.

nut diet (for magnesium intake)
calcium supplement dietDIETARY_SUPPLEMENT

Participants will consume assigned standardized meals including calcium supplements.

Calcium supplement diet (for calcium intake)
DASH dietDIETARY_SUPPLEMENT

Participants will consume assigned low salt high fruit meals following DASH diet guidance.

DASH Diet (for low-salt and high-fruit intake)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged between 18- and 60-year-old
  • Willing to join and complete the study

You may not qualify if:

  • Medical conditions, such as liver, kidney, gastrointestinal, or systemic diseases;
  • Drug taking or use within two weeks;
  • Pregnant women;
  • Lack of access to a smartphone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Westlake University

Hangzhou, Zhejiang, China

Location

MeSH Terms

Interventions

Dietary Approaches To Stop Hypertension

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The anticipated 40 participates are allocated to 5 parellel arms to verify the feasibility of device for testing 5 different urinary electrolytes to ensure 5-8 participates in each arms.
Purpose
DEVICE FEASIBILITY
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 25, 2026

First Posted

July 15, 2026

Study Start

July 20, 2026

Primary Completion (Estimated)

August 20, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

July 15, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations